Literature DB >> 14977568

Apoptosis in acute and chronic neurological disorders.

Oleksandr Ekshyyan1, Tak Yee Aw.   

Abstract

Programmed cell death or apoptosis is a physiologically important process in neurogenesis wherein approximately 50% of the neurons apoptose during maturation of the nervous system. However, premature apoptosis and/or aberrations in apoptosis control contribute to the pathogenesis of a variety of neurological disorders including acute brain injury such as trauma, spinal cord injury, ischemic stroke and ischemia/reperfusion as well as chronic disease states such as Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, spinal muscular atrophy, and diabetic neuropathy. The current review will focus on two major topics, namely, the general concepts of our current understanding of the apoptosis death machinery, its mediators and regulation, and the relationship between aberrant apoptosis and genesis of neurodegenerative disorders. This knowledge of apoptosis mechanisms will underpin the basis for development of novel therapeutic strategies and treatment modalities that are directed at control of the neuronal apoptotic death program.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14977568     DOI: 10.2741/1357

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  17 in total

1.  Protective effects of incensole acetate on cerebral ischemic injury.

Authors:  Arieh Moussaieff; Jin Yu; Hong Zhu; Sebastiano Gattoni-Celli; Esther Shohami; Mark S Kindy
Journal:  Brain Res       Date:  2012-01-09       Impact factor: 3.252

2.  Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats.

Authors:  Araceli Diaz-Ruiz; Hermelinda Salgado-Ceballos; Sergio Montes; Valente Maldonado; Luis Tristan; Mireya Alcaraz-Zubeldia; Camilo Ríos
Journal:  Neurochem Res       Date:  2006-12-09       Impact factor: 3.996

3.  Motoneuronotrophic factor analog GM6 reduces infarct volume and behavioral deficits following transient ischemia in the mouse.

Authors:  Jin Yu; Hong Zhu; Dorothy Ko; Mark S Kindy
Journal:  Brain Res       Date:  2008-08-29       Impact factor: 3.252

4.  Coenzyme Q10 Influences on the Levels of TNF-α and IL-10 and the Ratio of Bax/Bcl2 in a Menopausal Rat Model Following Lumbar Spinal Cord Injury.

Authors:  Sajad Hassanzadeh; Seyed Behnamedin Jameie; Maryam Soleimani; Mona Farhadi; Mahdieh Kerdari; Navid Danaei
Journal:  J Mol Neurosci       Date:  2018-06-14       Impact factor: 3.444

5.  Protective effects of ginsenoside Rb(3) on oxygen and glucose deprivation-induced ischemic injury in PC12 cells.

Authors:  Jun-rong Zhu; Yi-fu Tao; Shen Lou; Zi-mei Wu
Journal:  Acta Pharmacol Sin       Date:  2010-02-08       Impact factor: 6.150

6.  Anti-apoptotic effect of taxodione on serum/glucose deprivation-induced PC12 cells death.

Authors:  Negar Shafaei-Bajestani; Seyed Ahmad Emami; Javad Asili; Zahra Tayarani-Najaran
Journal:  Cell Mol Neurobiol       Date:  2014-09-04       Impact factor: 5.046

Review 7.  Diabetic neuropathy: cellular mechanisms as therapeutic targets.

Authors:  Andrea M Vincent; Brian C Callaghan; Andrea L Smith; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

8.  Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway.

Authors:  Xu Chen; Xuan Li; Wenyan Zhang; Jie He; Bo Xu; Bin Lei; Zhenhua Wang; Courtney Cates; Thomas Rousselle; Ji Li
Journal:  Metabolism       Date:  2018-03-09       Impact factor: 8.694

Review 9.  Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

Authors:  Chi-Tso Chiu; De-Maw Chuang
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

10.  Noscapine alleviates cerebral damage in ischemia-reperfusion injury in rats.

Authors:  Manisha Kawadkar; Avinash S Mandloi; Vidhu Saxena; Chetana Tamadaddi; Chandan Sahi; Vipin V Dhote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-27       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.